IceCure Medical Ltd. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
IceCure Medical Ltd. (ICCM) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $1.22 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-17.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-03-17
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|
| 2025-12-31 | $1.22M 20-F · filed 2026-03-17 | |
| 2025-06-30 | -$2.23M 6-K · filed 2025-08-13 | |
| 2024-12-31 | -$2.93M 20-F · filed 2026-03-17 | |
| 2024-06-30 | -$840.00K 6-K · filed 2025-08-13 | |
| 2023-12-31 | -$13.15M 20-F · filed 2026-03-17 | |
| 2023-06-30 | -$20.53M 6-K · filed 2024-08-20 | |
| 2022-12-31 | -$1.61M 20-F · filed 2025-03-27 | |
| 2022-06-30 | -$11.61M 6-K · filed 2023-08-14 | |
| 2021-12-31 | $22.08M 20-F · filed 2024-04-03 |